Atossa Therapeutics (ATOS) EBIT Margin (2011 - 2015)
Atossa Therapeutics (ATOS) recorded EBIT Margin of -140733.62% in Q4 2015, down 18053.37 percentage points from -122680.24% a year earlier.
Powered by 
Analysis
Atossa Therapeutics (ATOS) EBIT Margin (2011 - 2015) Analysis & Trends
For FY2015, Atossa Therapeutics reported EBIT Margin of -725746.19%, down 695423.23 percentage points from FY2014.
- Annual EBIT Margin has declined for three straight years, with a four-year change of -497133.52 percentage points (FY2011 to FY2015).
- Across earlier years, EBIT Margin came in at -30322.96% in FY2014 (-28618.03 pp), -1704.93% in FY2013 (-652.91 pp), -1052.01% in FY2012 (+227560.66 pp) and -228612.67% in FY2011.
- The Q4 2015 figure is the lowest quarterly EBIT Margin in data going back to Q4 2011.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 78086.81 percentage points in Q4 2012, against a drop of 116838.70 percentage points in Q4 2014 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 32.98% |
| 10 | Atossa Therapeutics | 19.96 Mn | -131.01 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | -140,733.62% |
| Dec 31, 2014 | -122,680.24% |
| Sep 30, 2014 | -94,724.31% |
| Jun 30, 2014 | -32,268.69% |
| Mar 31, 2014 | -9,993.89% |
| Dec 31, 2013 | -5,841.54% |
| Sep 30, 2013 | -4,571.85% |
| Jun 30, 2013 | -792.25% |
| Mar 31, 2013 | -1,062.81% |
| Dec 31, 2012 | -1,732.12% |
| Sep 30, 2012 | -1,075.69% |
| Jun 30, 2012 | -522.56% |
| Mar 31, 2012 | -1,941.34% |
| Dec 31, 2011 | -79,818.93% |
API Access
Atossa Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();